New patent expiration for Galderma Labs drug DIFFERIN

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for DIFFERIN
Annual Drug Patent Expirations for DIFFERIN

Differin is a drug marketed by Galderma Labs Lp and is included in five NDAs. It is available from five suppliers. There are nine patents protecting this drug and one Paragraph IV challenge.

DIFFERIN drug price trends.

This drug has fifty patent family members in twenty-two countries.

The generic ingredient in DIFFERIN is adapalene. Five suppliers are listed for this compound. Additional details are available on the adapalene profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top